David Glen Moreland

US Patent:

6343938, Feb 5, 2002

Filed:

Aug 30, 2000

Appl. No.:

09/651084

Inventors:

David R. Moreland - Euless TX 76039

International Classification:

G09B 2309

US Classification:

434284, 434292, 40540

Abstract:

An educational astronautical system for instructing students in the cause and result of the phases of the moon. A hollow outer sphere has a smaller inner sphere mounted in the center of the inside space of the outer sphere. The inner sphere resembles the surface of the moon. A light source ifs provided on the equator of the outer sphere to illuminate the surface of the inner sphere. A eight viewing stations are provided, equally spaced around the equator of the outer sphere, one of said viewing stations being placed coincident with the light source whereby viewing the inner sphere from different stations gives the viewer a picture of a different phase of the moon at each station.

US Patent:

20050004167, Jan 6, 2005

Filed:

Jan 26, 2004

Appl. No.:

10/765002

Inventors:

Keenan Bora - Philadelphia PA, US
Suzanne Kesten - Ann Arbor MI, US
David Moreland - Ann Arbor MI, US
Michael Rafferty - Ann Arbor MI, US
Todd Ryder - Rochester NY, US
Jeffrey Scholten - Ann Arbor MI, US
David Wustrow - Ann Arbor MI, US

International Classification:

A61K031/47
A61K031/403
A61K031/405
A61K031/381
A61K031/343

US Classification:

514311000, 514411000, 514419000, 514444000, 514468000, 514469000, 546169000, 548444000, 548495000, 549048000, 549458000, 549462000

Abstract:

The invention relates to BCAT inhibitor compounds of formula (I) and use thereof for treating or preventing neuronal loss associated with stroke, ischemia, CNS trauma, hypoglycemia and surgery, as well as treating neurodegenerative diseases including Alzheimer's disease, amyotrophic lateral sclerosis, Huntington's disease and Down's syndrome, treating or preventing the adverse consequences of the overstimulation of the excitatory amino acids, treating anxiety, psychosis, convulsions, aminoglycoside antibiotics-induced hearing loss, migraine headache, chronic pain, neuropathic pain, Parkinson's disease, diabetic retinopathy, glaucoma, CMV retinitis, urinary incontinence, opioid tolerance or withdrawal, and inducing anesthesia, as well as for enhancing cognition.